Lunai Bioworks (LNAI) Stock Statistics & Valuation Metrics

Lunai Bioworks has a market cap or net worth of $23.25M. The enterprise value is ―.

Lunai Bioworks has 23,430,653 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lunai Bioworks’s return on equity (ROE) is 8.34 and return on invested capital (ROIC) is 1690.77%.

The current PE Ratio of Lunai Bioworks is ―. Lunai Bioworks’s PEG ratio is -0.01.

In the last 12 months, Lunai Bioworks had revenue of 0.00 and earned -178.01M in profits. Earnings per share was -10.78.

In the last 12 months, operating cash flow was -7.21M and capital expenditures 0.00, giving a free cash flow of -7.21M billion.

Lunai Bioworks pays an annual dividend of ―, resulting in a dividend yield of ―

Lunai Bioworks upcoming earnings date is ―, ―.

Lunai Bioworks as a current ratio of 0.04, with Debt / Equity ratio of -20.76%

In the past 12 months, Lunai Bioworks has paid 0.00 in taxes.

Lunai Bioworks EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -6.06.

Lunai Bioworks has $624.81K in cash and marketable securities with $2.71M in debt, giving a net cash position of -$2.08M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Lunai Bioworks is ―, which is 11.43% higher than the current price. The consensus rating is ―